annual Report 2009 - STRATEC Biomedical AG

Financial liabilities had the following maturity structure as of December 31, 2009:
in v thousand 12.31.2009 12.31.2009 12.31.2008 12.31.2008
Remaining term
Up to 1 year 488 447
of which current liabilities 44 2
of which current portion of non-current liabilities 444 445
1 year to 5 years 2,556 2,146
More than 5 years 3,046 3,515
Total 6,090 6,108
Company land in Germany had been encumbered with a land charge of u 2,000 thousand as security for bank loans
(previous year: u 2,000 thousand).
The following table shows the contractually agreed interest and principal payments (in u thousand) and weighted interest
rates (%):
in % / in v thousand
Carrying
amount
12.31.2009 Cash flow in 2010 Cash flow in 2011
Cash flows
in 2012 – 2014
Cash flows
in 2015 onwards
Interest Principal Interest Principal Interest Principal Interest Principal
Overdraft 44 3 44 0 0 0 0 0 0
Loans and silent
partnership liabilities 6,046 206 449 189 464 432 2,623 147 2,509
Total 6,090 209 493 189 464 432 2,623 147 2,509
The loans with terms of up to 5 years charge interest at a weighted average rate of 5.03%, while the weighted average
rate for loans with terms of more than 5 years amounts to 3.06%.
in % / in v thousand
Carrying
amount
12.31.2008 Cash flow in 2009 Cash flow in 2010
Cash flows
in 2011 – 2013
Cash flows
in 2014 onwards
Interest Principal Interest Principal Interest Principal Interest Principal
Overdraft 2 0 2 0 0 0 0 0 0
Loans 6,106 189 445 131 427 411 1,719 171 3,515
Total 6,108 189 447 131 427 411 1,719 171 3,515
The loans with terms of up to 5 years as of December 31, 2008 charged interest at a weighted average rate of 5.11%,
while the weighted average rate for loans with terms of more than 5 years amounted to 3.09 %.
(17) Trade payables / liabilities to associates
Trade payables mostly involve goods and services provided in November and December 2009 and are due for payment
within one year.
The liabilities to associates amounting to u 24 thousand (previous year: u 70 thousand) are due to STRATEC NewGen GmbH
(u 19 thousand; previous year: u 25 thousand) and to STRATEC Biomedical Systems S.R.L., Romania, (u 5 thousand;
previous year: u 45 thousand), and relate to the ongoing exchange of goods and services.
These liabilities are assigned to the “Financial liabilities measured at amortized cost” (LMAC) category pursuant to IAS 39.
90 stratec Annual Report 2009